Football baseball basketball soccer hockey Germany boosts own vaccine makers in race for COVID-19 jab

Football baseball basketball soccer Hockey

Football baseball basketball soccer Hockey Germany says it is providing up to $892 million to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus

September 15, 2020, 11: 38 AM

1 min read

BERLIN — Germany says it is providing up to 750 million euros ($892 million) to support three domestic pharmaceutical companies that are developingvaccinesagainst the newcoronavirus.

Science Minister Anja Karliczek said the government has already agreed to provide BioNTech and CureVac with 375 million euros and 230-million euros respectively to develop their mRNA-basedvaccines.

Talks with a third company, IDT Biologika, are expected to conclude soon, she said. The company is developing a vector-based vaccine that delivers a coronavirus protein into cells to stimulate the body’s immune response.

The agreement with the three companies, which is tied to specific milestones, would guaranteeGermany40 million doses of vaccine. This comes on top of other vaccine supply agreements concluded through the European Union, of whichGermanyis a member.



Read More